VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the 2012 Wells Fargo Securities Healthcare Conference on Tuesday, June 19, 2012 at 3:00 PM (ET) at the InterContinental Hotel in Boston.
